Efficacy of Short Term Dabigatran Etexilate Followed by Aspirin Monotherapy After LAA (Left Atrial Appendage) Device Closure (the DEA-LAA Study).

NCT03539055 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Atrial Fibrillation
Device Related Thrombus
Left Atrial Appendage Thrombosis
Watchman LAA Closure Device

Interventions

DRUG: Dabigatran Etexilate Oral Capsule

Sponsor

Vanderbilt University Medical Center

Collaborators

[object Object]